Industry Research Reports

Home > Reports > Pharma & Healthcare > Anisodamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Anisodamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-01-11

Pages: 120 Pages

Report ld: 2634886

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Anisodamine Market Size(US$)

CAGR 2024-2030

3.7%

Market Size,2030

USD 104.7

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 84 million

Market Forecast in 2030(Value)

US$ 104.7 million

CAGR

3.7%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.

The global market for Anisodamine was estimated to be worth US$ 79 million in 2023 and is forecast to a readjusted size of US$ 104.7 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Merck
ALB Technology Limited
Northeast Pharmaceutical Group
Dayang chem (Hangzhou)
Wuhan WUJING MEDICINE
Hangzhou Minsheng Pharmaceutical
HENAN PURUI MEDICINE
BRILLIANT PHARMACEUTICALS
Qingdao Huanghai Pharmaceutical
Nanjing Tianlang Pharmaceutical
Henan Kangqian Medical Technology
Shanghai yuanye Bio-Technology
Wsembio

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Injection
Tablet
Drops

Segment by Application

Visceral
Brain
Eyes
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Anisodamine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anisodamine by region & country, by Type, and by Application.

The Anisodamine market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anisodamine.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Anisodamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Anisodamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Anisodamine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Anisodamine Product Introduction

1.2 Global Anisodamine Market Size Forecast

1.2.1 Global Anisodamine Sales Value (2019-2030)

1.2.2 Global Anisodamine Sales Volume (2019-2030)

1.2.3 Global Anisodamine Sales Price (2019-2030)

1.3 Anisodamine Market Trends & Drivers

1.3.1 Anisodamine Industry Trends

1.3.2 Anisodamine Market Drivers & Opportunity

1.3.3 Anisodamine Market Challenges

1.3.4 Anisodamine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Anisodamine Players Revenue Ranking (2023)

2.2 Global Anisodamine Revenue by Company (2019-2024)

2.3 Global Anisodamine Players Sales Volume Ranking (2023)

2.4 Global Anisodamine Sales Volume by Company Players (2019-2024)

2.5 Global Anisodamine Average Price by Company (2019-2024)

2.6 Key Manufacturers Anisodamine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Anisodamine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Anisodamine

2.9 Anisodamine Market Competitive Analysis

2.9.1 Anisodamine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Anisodamine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anisodamine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Injection

3.1.2 Tablet

3.1.3 Drops

3.2 Global Anisodamine Sales Value by Type

3.2.1 Global Anisodamine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Anisodamine Sales Value, by Type (2019-2030)

3.2.3 Global Anisodamine Sales Value, by Type (%) (2019-2030)

3.3 Global Anisodamine Sales Volume by Type

3.3.1 Global Anisodamine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Anisodamine Sales Volume, by Type (2019-2030)

3.3.3 Global Anisodamine Sales Volume, by Type (%) (2019-2030)

3.4 Global Anisodamine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Visceral

4.1.2 Brain

4.1.3 Eyes

4.1.4 Others

4.2 Global Anisodamine Sales Value by Application

4.2.1 Global Anisodamine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Anisodamine Sales Value, by Application (2019-2030)

4.2.3 Global Anisodamine Sales Value, by Application (%) (2019-2030)

4.3 Global Anisodamine Sales Volume by Application

4.3.1 Global Anisodamine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Anisodamine Sales Volume, by Application (2019-2030)

4.3.3 Global Anisodamine Sales Volume, by Application (%) (2019-2030)

4.4 Global Anisodamine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Anisodamine Sales Value by Region

5.1.1 Global Anisodamine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Anisodamine Sales Value by Region (2019-2024)

5.1.3 Global Anisodamine Sales Value by Region (2025-2030)

5.1.4 Global Anisodamine Sales Value by Region (%), (2019-2030)

5.2 Global Anisodamine Sales Volume by Region

5.2.1 Global Anisodamine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Anisodamine Sales Volume by Region (2019-2024)

5.2.3 Global Anisodamine Sales Volume by Region (2025-2030)

5.2.4 Global Anisodamine Sales Volume by Region (%), (2019-2030)

5.3 Global Anisodamine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Anisodamine Sales Value, 2019-2030

5.4.2 North America Anisodamine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Anisodamine Sales Value, 2019-2030

5.5.2 Europe Anisodamine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Anisodamine Sales Value, 2019-2030

5.6.2 Asia Pacific Anisodamine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Anisodamine Sales Value, 2019-2030

5.7.2 South America Anisodamine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Anisodamine Sales Value, 2019-2030

5.8.2 Middle East & Africa Anisodamine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Anisodamine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Anisodamine Sales Value

6.2.1 Key Countries/Regions Anisodamine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Anisodamine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Anisodamine Sales Value, 2019-2030

6.3.2 United States Anisodamine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Anisodamine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Anisodamine Sales Value, 2019-2030

6.4.2 Europe Anisodamine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Anisodamine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Anisodamine Sales Value, 2019-2030

6.5.2 China Anisodamine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Anisodamine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Anisodamine Sales Value, 2019-2030

6.6.2 Japan Anisodamine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Anisodamine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Anisodamine Sales Value, 2019-2030

6.7.2 South Korea Anisodamine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Anisodamine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Anisodamine Sales Value, 2019-2030

6.8.2 Southeast Asia Anisodamine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Anisodamine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Anisodamine Sales Value, 2019-2030

6.9.2 India Anisodamine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Anisodamine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Anisodamine Product Offerings

7.1.5 Merck Recent Development

7.2 ALB Technology Limited

7.2.1 ALB Technology Limited Company Information

7.2.2 ALB Technology Limited Introduction and Business Overview

7.2.3 ALB Technology Limited Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 ALB Technology Limited Anisodamine Product Offerings

7.2.5 ALB Technology Limited Recent Development

7.3 Northeast Pharmaceutical Group

7.3.1 Northeast Pharmaceutical Group Company Information

7.3.2 Northeast Pharmaceutical Group Introduction and Business Overview

7.3.3 Northeast Pharmaceutical Group Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Northeast Pharmaceutical Group Anisodamine Product Offerings

7.3.5 Northeast Pharmaceutical Group Recent Development

7.4 Dayang chem (Hangzhou)

7.4.1 Dayang chem (Hangzhou) Company Information

7.4.2 Dayang chem (Hangzhou) Introduction and Business Overview

7.4.3 Dayang chem (Hangzhou) Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Dayang chem (Hangzhou) Anisodamine Product Offerings

7.4.5 Dayang chem (Hangzhou) Recent Development

7.5 Wuhan WUJING MEDICINE

7.5.1 Wuhan WUJING MEDICINE Company Information

7.5.2 Wuhan WUJING MEDICINE Introduction and Business Overview

7.5.3 Wuhan WUJING MEDICINE Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Wuhan WUJING MEDICINE Anisodamine Product Offerings

7.5.5 Wuhan WUJING MEDICINE Recent Development

7.6 Hangzhou Minsheng Pharmaceutical

7.6.1 Hangzhou Minsheng Pharmaceutical Company Information

7.6.2 Hangzhou Minsheng Pharmaceutical Introduction and Business Overview

7.6.3 Hangzhou Minsheng Pharmaceutical Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Hangzhou Minsheng Pharmaceutical Anisodamine Product Offerings

7.6.5 Hangzhou Minsheng Pharmaceutical Recent Development

7.7 HENAN PURUI MEDICINE

7.7.1 HENAN PURUI MEDICINE Company Information

7.7.2 HENAN PURUI MEDICINE Introduction and Business Overview

7.7.3 HENAN PURUI MEDICINE Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 HENAN PURUI MEDICINE Anisodamine Product Offerings

7.7.5 HENAN PURUI MEDICINE Recent Development

7.8 BRILLIANT PHARMACEUTICALS

7.8.1 BRILLIANT PHARMACEUTICALS Company Information

7.8.2 BRILLIANT PHARMACEUTICALS Introduction and Business Overview

7.8.3 BRILLIANT PHARMACEUTICALS Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 BRILLIANT PHARMACEUTICALS Anisodamine Product Offerings

7.8.5 BRILLIANT PHARMACEUTICALS Recent Development

7.9 Qingdao Huanghai Pharmaceutical

7.9.1 Qingdao Huanghai Pharmaceutical Company Information

7.9.2 Qingdao Huanghai Pharmaceutical Introduction and Business Overview

7.9.3 Qingdao Huanghai Pharmaceutical Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Qingdao Huanghai Pharmaceutical Anisodamine Product Offerings

7.9.5 Qingdao Huanghai Pharmaceutical Recent Development

7.10 Nanjing Tianlang Pharmaceutical

7.10.1 Nanjing Tianlang Pharmaceutical Company Information

7.10.2 Nanjing Tianlang Pharmaceutical Introduction and Business Overview

7.10.3 Nanjing Tianlang Pharmaceutical Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Nanjing Tianlang Pharmaceutical Anisodamine Product Offerings

7.10.5 Nanjing Tianlang Pharmaceutical Recent Development

7.11 Henan Kangqian Medical Technology

7.11.1 Henan Kangqian Medical Technology Company Information

7.11.2 Henan Kangqian Medical Technology Introduction and Business Overview

7.11.3 Henan Kangqian Medical Technology Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Henan Kangqian Medical Technology Anisodamine Product Offerings

7.11.5 Henan Kangqian Medical Technology Recent Development

7.12 Shanghai yuanye Bio-Technology

7.12.1 Shanghai yuanye Bio-Technology Company Information

7.12.2 Shanghai yuanye Bio-Technology Introduction and Business Overview

7.12.3 Shanghai yuanye Bio-Technology Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Shanghai yuanye Bio-Technology Anisodamine Product Offerings

7.12.5 Shanghai yuanye Bio-Technology Recent Development

7.13 Wsembio

7.13.1 Wsembio Company Information

7.13.2 Wsembio Introduction and Business Overview

7.13.3 Wsembio Anisodamine Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Wsembio Anisodamine Product Offerings

7.13.5 Wsembio Recent Development

8 Industry Chain Analysis

8.1 Anisodamine Industrial Chain

8.2 Anisodamine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Anisodamine Sales Model

8.5.2 Sales Channel

8.5.3 Anisodamine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Anisodamine Market Trends

Table 2. Anisodamine Market Drivers & Opportunity

Table 3. Anisodamine Market Challenges

Table 4. Anisodamine Market Restraints

Table 5. Global Anisodamine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Anisodamine Revenue Market Share by Company (2019-2024)

Table 7. Global Anisodamine Sales Volume by Company (2019-2024) & (Ton)

Table 8. Global Anisodamine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Anisodamine Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Anisodamine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Anisodamine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Anisodamine

Table 13. Global Anisodamine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anisodamine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Anisodamine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Anisodamine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Anisodamine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Anisodamine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Anisodamine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Anisodamine Sales Volume by Type: 2019 VS 2023 VS 2030 (Ton)

Table 22. Global Anisodamine Sales Volume by Type (2019-2024) & (Ton)

Table 23. Global Anisodamine Sales Volume by Type (2025-2030) & (Ton)

Table 24. Global Anisodamine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Anisodamine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Anisodamine Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Anisodamine Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Anisodamine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Anisodamine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Anisodamine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Anisodamine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Anisodamine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Anisodamine Sales Volume by Application: 2019 VS 2023 VS 2030 (Ton)

Table 34. Global Anisodamine Sales Volume by Application (2019-2024) & (Ton)

Table 35. Global Anisodamine Sales Volume by Application (2025-2030) & (Ton)

Table 36. Global Anisodamine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Anisodamine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Anisodamine Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Anisodamine Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Anisodamine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Anisodamine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Anisodamine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Anisodamine Sales Value by Region (2019-2024) & (%)

Table 44. Global Anisodamine Sales Value by Region (2025-2030) & (%)

Table 45. Global Anisodamine Sales Volume by Region (Ton): 2019 VS 2023 VS 2030

Table 46. Global Anisodamine Sales Volume by Region (2019-2024) & (Ton)

Table 47. Global Anisodamine Sales Volume by Region (2025-2030) & (Ton)

Table 48. Global Anisodamine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Anisodamine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Anisodamine Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Anisodamine Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Anisodamine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Anisodamine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Anisodamine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Anisodamine Sales Volume, (2019-2024) & (Ton)

Table 56. Key Countries/Regions Anisodamine Sales Volume, (2025-2030) & (Ton)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. Merck Anisodamine Product Offerings

Table 61. Merck Recent Development

Table 62. ALB Technology Limited Company Information

Table 63. ALB Technology Limited Introduction and Business Overview

Table 64. ALB Technology Limited Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. ALB Technology Limited Anisodamine Product Offerings

Table 66. ALB Technology Limited Recent Development

Table 67. Northeast Pharmaceutical Group Company Information

Table 68. Northeast Pharmaceutical Group Introduction and Business Overview

Table 69. Northeast Pharmaceutical Group Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Northeast Pharmaceutical Group Anisodamine Product Offerings

Table 71. Northeast Pharmaceutical Group Recent Development

Table 72. Dayang chem (Hangzhou) Company Information

Table 73. Dayang chem (Hangzhou) Introduction and Business Overview

Table 74. Dayang chem (Hangzhou) Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Dayang chem (Hangzhou) Anisodamine Product Offerings

Table 76. Dayang chem (Hangzhou) Recent Development

Table 77. Wuhan WUJING MEDICINE Company Information

Table 78. Wuhan WUJING MEDICINE Introduction and Business Overview

Table 79. Wuhan WUJING MEDICINE Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. Wuhan WUJING MEDICINE Anisodamine Product Offerings

Table 81. Wuhan WUJING MEDICINE Recent Development

Table 82. Hangzhou Minsheng Pharmaceutical Company Information

Table 83. Hangzhou Minsheng Pharmaceutical Introduction and Business Overview

Table 84. Hangzhou Minsheng Pharmaceutical Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. Hangzhou Minsheng Pharmaceutical Anisodamine Product Offerings

Table 86. Hangzhou Minsheng Pharmaceutical Recent Development

Table 87. HENAN PURUI MEDICINE Company Information

Table 88. HENAN PURUI MEDICINE Introduction and Business Overview

Table 89. HENAN PURUI MEDICINE Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. HENAN PURUI MEDICINE Anisodamine Product Offerings

Table 91. HENAN PURUI MEDICINE Recent Development

Table 92. BRILLIANT PHARMACEUTICALS Company Information

Table 93. BRILLIANT PHARMACEUTICALS Introduction and Business Overview

Table 94. BRILLIANT PHARMACEUTICALS Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. BRILLIANT PHARMACEUTICALS Anisodamine Product Offerings

Table 96. BRILLIANT PHARMACEUTICALS Recent Development

Table 97. Qingdao Huanghai Pharmaceutical Company Information

Table 98. Qingdao Huanghai Pharmaceutical Introduction and Business Overview

Table 99. Qingdao Huanghai Pharmaceutical Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 100. Qingdao Huanghai Pharmaceutical Anisodamine Product Offerings

Table 101. Qingdao Huanghai Pharmaceutical Recent Development

Table 102. Nanjing Tianlang Pharmaceutical Company Information

Table 103. Nanjing Tianlang Pharmaceutical Introduction and Business Overview

Table 104. Nanjing Tianlang Pharmaceutical Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 105. Nanjing Tianlang Pharmaceutical Anisodamine Product Offerings

Table 106. Nanjing Tianlang Pharmaceutical Recent Development

Table 107. Henan Kangqian Medical Technology Company Information

Table 108. Henan Kangqian Medical Technology Introduction and Business Overview

Table 109. Henan Kangqian Medical Technology Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 110. Henan Kangqian Medical Technology Anisodamine Product Offerings

Table 111. Henan Kangqian Medical Technology Recent Development

Table 112. Shanghai yuanye Bio-Technology Company Information

Table 113. Shanghai yuanye Bio-Technology Introduction and Business Overview

Table 114. Shanghai yuanye Bio-Technology Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 115. Shanghai yuanye Bio-Technology Anisodamine Product Offerings

Table 116. Shanghai yuanye Bio-Technology Recent Development

Table 117. Wsembio Company Information

Table 118. Wsembio Introduction and Business Overview

Table 119. Wsembio Anisodamine Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 120. Wsembio Anisodamine Product Offerings

Table 121. Wsembio Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Anisodamine Downstream Customers

Table 125. Anisodamine Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Anisodamine Product Picture

Figure 2. Global Anisodamine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anisodamine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Anisodamine Sales Volume (2019-2030) & (Ton)

Figure 5. Global Anisodamine Sales Price (2019-2030) & (US$/Ton)

Figure 6. Anisodamine Report Years Considered

Figure 7. Global Anisodamine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Anisodamine Players Sales Volume Ranking (2023) & (Ton)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anisodamine Revenue in 2023

Figure 10. Anisodamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Injection Picture

Figure 12. Tablet Picture

Figure 13. Drops Picture

Figure 14. Global Anisodamine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Anisodamine Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Anisodamine Sales Volume by Type (2019 VS 2023 VS 2030) & (Ton)

Figure 17. Global Anisodamine Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Anisodamine Price by Type (2019-2030) & (US$/Ton)

Figure 19. Product Picture of Visceral

Figure 20. Product Picture of Brain

Figure 21. Product Picture of Eyes

Figure 22. Product Picture of Others

Figure 23. Global Anisodamine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Anisodamine Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Anisodamine Sales Volume by Application (2019 VS 2023 VS 2030) & (Ton)

Figure 26. Global Anisodamine Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Anisodamine Price by Application (2019-2030) & (US$/Ton)

Figure 28. North America Anisodamine Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Anisodamine Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Anisodamine Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Anisodamine Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Anisodamine Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Anisodamine Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Anisodamine Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Anisodamine Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Anisodamine Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Anisodamine Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Anisodamine Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Anisodamine Sales Volume (%), (2019-2030)

Figure 40. United States Anisodamine Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Anisodamine Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Anisodamine Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Anisodamine Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Anisodamine Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Anisodamine Sales Value by Application (%), 2023 VS 2030

Figure 46. China Anisodamine Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Anisodamine Sales Value by Type (%), 2023 VS 2030

Figure 48. China Anisodamine Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Anisodamine Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Anisodamine Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Anisodamine Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Anisodamine Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Anisodamine Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Anisodamine Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Anisodamine Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Anisodamine Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Anisodamine Sales Value by Application (%), 2023 VS 2030

Figure 58. India Anisodamine Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Anisodamine Sales Value by Type (%), 2023 VS 2030

Figure 60. India Anisodamine Sales Value by Application (%), 2023 VS 2030

Figure 61. Anisodamine Industrial Chain

Figure 62. Anisodamine Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Anisodamine in 2030? zhanKai

The global market size of Anisodamine in 2030 was 104.7 Million USD.

What is the annual compound growth rate of the global Anisodamine market size from 2024 to 2030? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Anisodamine in 2024? shouQi

Which companies rank high in the global Anisodamine market? shouQi

Related Reports

Global Anisodamine Market Research Report 2025
The global market for Anisodamine was valued at US$ 84.2 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published Date: 2025-01-01
Pages: 96
USD 2900.00
(Single User License)
Global Anisodamine Market Research Report 2024
Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.
Published Date: 2024-01-21
Pages: 87
USD 2900.00
(Single User License)

Global Anisodamine Market Research Report 2025
The global market for Anisodamine was valued at US$ 84.2 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published: 2025-01-01
Pages: 96
USD 2900.00 (Single User License)
Global Anisodamine Market Research Report 2024
Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.
Published: 2024-01-21
Pages: 87
USD 2900.00 (Single User License)